• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙内酰脲衍生物的生物制药研究。I. 乙内酰脲衍生物的物理化学性质及其肠道吸收

Biopharmaceutical studies on hydantoin derivatives. I. Physico-chemical properties of hydantoin derivatives and their intestinal absorption.

作者信息

Fujioka H, Tan T

出版信息

J Pharmacobiodyn. 1981 Oct;4(10):759-70. doi: 10.1248/bpb1978.4.759.

DOI:10.1248/bpb1978.4.759
PMID:7320829
Abstract

The physico-chemical properties of a series of hydantoin derivatives and their intestinal absorption from solution were studied. The introduction of the benzenesulfonyl group at the 1-position of the hydantoin ring greatly affects the physico-chemical properties: the acid dissociation constants were increased 1000-fold and the partition coefficients were increased 100- to 1000-fold in the chloroform/water system and 10- to 100-fold in the n-octanol/water system. The solubilities of 1-benzenesulfonylhydantoin derivatives increased with increasing pH of the solution at pH more than 5, but the solubilities of the 1- unsubstituted hydantoin derivatives were scarcely dependent on the pH of the solution in the pH 1 to 8 region. The intestinal absorption from solution was found to be caused by the passive transport according to the first-order kinetics. The rate constants of absorption of 1-benzenesulfonylhydantoin derivatives were rather large even under the condition where they were 99% ionized in the solution than that of the corresponding 1-unsubstituted hydantoin derivatives which exist mainly as the unionized from under the same condition. The intestinal absorption from a solution and the partitioning to chloroform produced linear free energy relationships to each other for the 1-benzenesulfonylhydatoin derivatives and for the 1-unsubstituted hydantoin derivatives independently. However when the partition coefficients in the n-octanol/water system were applied, the hydroxyl derivatives were found to deviate from linear relationships. On the basis of the results, a suggestion was made on the in vivo behavior and the bioavailability.

摘要

研究了一系列乙内酰脲衍生物的物理化学性质及其在溶液中的肠道吸收情况。在乙内酰脲环的1位引入苯磺酰基极大地影响了物理化学性质:在氯仿/水体系中,酸解离常数增加了1000倍,分配系数增加了100至1000倍;在正辛醇/水体系中,分配系数增加了10至100倍。1-苯磺酰基乙内酰脲衍生物的溶解度在pH大于5时随溶液pH值的升高而增加,但1-未取代乙内酰脲衍生物的溶解度在pH 1至8范围内几乎不依赖于溶液的pH值。发现溶液中的肠道吸收是由一级动力学的被动转运引起的。即使在溶液中99%离子化的条件下,1-苯磺酰基乙内酰脲衍生物的吸收速率常数也比相应的1-未取代乙内酰脲衍生物大得多,后者在相同条件下主要以非离子形式存在。对于1-苯磺酰基乙内酰脲衍生物和1-未取代乙内酰脲衍生物,溶液中的肠道吸收和分配到氯仿之间分别产生了线性自由能关系。然而,当应用正辛醇/水体系中的分配系数时,发现羟基衍生物偏离了线性关系。基于这些结果,对体内行为和生物利用度提出了建议。

相似文献

1
Biopharmaceutical studies on hydantoin derivatives. I. Physico-chemical properties of hydantoin derivatives and their intestinal absorption.乙内酰脲衍生物的生物制药研究。I. 乙内酰脲衍生物的物理化学性质及其肠道吸收
J Pharmacobiodyn. 1981 Oct;4(10):759-70. doi: 10.1248/bpb1978.4.759.
2
Biopharmaceutical studies on hydantoin derivatives. II. Pharmacokinetics and bioavailability of hydantoin derivatives in dogs.乙内酰脲衍生物的生物制药研究。II. 乙内酰脲衍生物在犬体内的药代动力学和生物利用度。
J Pharmacobiodyn. 1982 Mar;5(3):141-7. doi: 10.1248/bpb1978.5.141.
3
Biopharmaceutical studies on hydantoin derivatives. III. Physico-chemical properties, dissolution behavior, and bioavailability of the molecular compound of 1-benzenesulfonyl-5,5-diphenylhydantoin and antipyrine.乙内酰脲衍生物的生物制药研究。III. 1-苯磺酰基-5,5-二苯基乙内酰脲与安替比林分子化合物的物理化学性质、溶解行为及生物利用度
J Pharmacobiodyn. 1982 Jul;5(7):475-84. doi: 10.1248/bpb1978.5.475.
4
Gastrointestinal absorption of the strongly acidic drug proxicromil.强酸性药物丙酰半胱氨酸的胃肠道吸收。
J Pharm Sci. 1984 Jul;73(7):949-53. doi: 10.1002/jps.2600730722.
5
Physicochemical and biopharmaceutical characterization of BTA-243, a diacidic drug with low oral bioavailability.BTA-243(一种口服生物利用度低的二元酸药物)的物理化学和生物药剂学特性
Int J Pharm. 2001 Feb 1;213(1-2):127-34. doi: 10.1016/s0378-5173(00)00657-8.
6
Partitioning phenomena in dosage form and biopharmaceutical design. I. Prognostic significance of partition coefficients.剂型与生物药剂学设计中的分配现象。I. 分配系数的预后意义。
Am J Hosp Pharm. 1971 Oct;28(10):796-9.
7
A membrane model of the human oral mucosa as derived from buccal absorption performance and physicochemical properties of the beta-blocking drugs atenolol and propranolol.
J Pharm Pharmacol. 1978 Mar;30(3):137-47. doi: 10.1111/j.2042-7158.1978.tb13185.x.
8
Kinetics of carboxymethylation of histidine hydantoin.组氨酸乙内酰脲的羧甲基化动力学
Biochemistry. 1979 Sep 4;18(18):3933-8. doi: 10.1021/bi00585a014.
9
Physical model approach to gastrointestinal absorption of prostaglandins III: In situ rat intestinal absorption of dinoprostone.
J Pharm Sci. 1984 Nov;73(11):1594-9. doi: 10.1002/jps.2600731127.
10
In vitro and in situ absorption of etamsylate. Part 2: In vitro and in situ properties.酚磺乙胺的体外和原位吸收。第2部分:体外和原位性质。
Pharmazie. 1992 Apr;47(4):282-5.